Reaction Details Report a problem with these data
Target
Cytochrome P450 2C19
Ligand
BDBM50448496
Substrate
n/a
Meas. Tech.
ChEMBL_1294676 (CHEMBL3128673)
EC50
>40000±n/a nM
Citation
 Gentles, RG; Ding, M; Bender, JA; Bergstrom, CP; Grant-Young, K; Hewawasam, P; Hudyma, T; Martin, S; Nickel, A; Regueiro-Ren, A; Tu, Y; Yang, Z; Yeung, KS; Zheng, X; Chao, S; Sun, JH; Beno, BR; Camac, DM; Chang, CH; Gao, M; Morin, PE; Sheriff, S; Tredup, J; Wan, J; Witmer, MR; Xie, D; Hanumegowda, U; Knipe, J; Mosure, K; Santone, KS; Parker, DD; Zhuo, X; Lemm, J; Liu, M; Pelosi, L; Rigat, K; Voss, S; Wang, Y; Wang, YK; Colonno, RJ; Gao, M; Roberts, SB; Gao, Q; Ng, A; Meanwell, NA; Kadow, JF Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase. J Med Chem 57:1855-79 (2014) [PubMed]  Article 
Target
Name:
Cytochrome P450 2C19
Synonyms:
CP2CJ_HUMAN | CYP2C19 | CYPIIC17 | CYPIIC19 | Cytochrome P450 2C19 (CYP2C19) | Cytochrome P450 2C19 [I331V] | Mephenytoin 4-hydroxylase | P450-11A | P450-254C
Type:
Enzyme
Mol. Mass.:
55935.47
Organism:
Homo sapiens (Human)
Description:
P33261
Residue:
490
Sequence:
MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKIYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFMESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYIDLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFKKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVPPFYQLCFIPV
  
Inhibitor
Name:
BDBM50448496
Synonyms:
CHEMBL3126835
Type:
Small organic molecule
Emp. Form.:
C36H45N5O5S
Mol. Mass.:
659.838
SMILES:
CCN1CC2CC(C1)N2C(=O)[C@]12C[C@H]1c1cc(OC)ccc1-c1c(C3CCCCC3)c3ccc(cc3n1C2)C(=O)NS(=O)(=O)N(C)C |r,TLB:9:8:3.2.7:5,1:2:8:5|
Structure:
Search PDB for entries with ligand similarity: